Millendo Therapeutics, Inc.
Q2 2020 13F Holders
Symbol
MLND
CUSIP
60040X103
Type
Equity
Class
COM
Num filings
68
Total reported value, excl. options
$14.8 M
Compare 2020 Q2 to
2021 Q1
2020 Q4
2020 Q3
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2019 Q1
2018 Q4
Manager
Report Date
Value ($000)
Shares
Option Type